Lobbying client
EDITAS MEDICINES, INC.
Biotechnology Company
Filings
18
Filed by
1
Reported in-house
—
Reported by firms
$670,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2016 to 2020
Filings
18 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2020
|
FOLEY HOAG LLP | — reported |
|
1st Quarter - Report 1st Quarter 2020
|
FOLEY HOAG LLP | $40,000 reported |
|
4th Quarter - Report 4th Quarter 2019
|
FOLEY HOAG LLP | $40,000 reported |
|
3rd Quarter - Report 3rd Quarter 2019
|
FOLEY HOAG LLP | $40,000 reported |
|
2nd Quarter - Report 2nd Quarter 2019
|
FOLEY HOAG LLP | $40,000 reported |
|
1st Quarter - Report 1st Quarter 2019
|
FOLEY HOAG LLP | $40,000 reported |
|
4th Quarter - Report 4th Quarter 2018
|
FOLEY HOAG LLP | $40,000 reported |
|
3rd Quarter - Report 3rd Quarter 2018
|
FOLEY HOAG LLP | $40,000 reported |
|
2nd Quarter - Report 2nd Quarter 2018
|
FOLEY HOAG LLP | $40,000 reported |
|
1st Quarter - Report 1st Quarter 2018
|
FOLEY HOAG LLP | $40,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FOLEY HOAG LLP | 17 | $670,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 17 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.